<DOC>
	<DOCNO>NCT02286973</DOCNO>
	<brief_summary>This prospective randomized control trial conduct To compare efficacy TNA term total blood loss allogenic transfusion rate among three study group ; intravenous alone , combine intravenous low dose topical TNA combine intravenous high dose topical TNA . To evaluate safety regimen view deep vein thrombosis venous thromboembolism .</brief_summary>
	<brief_title>Combined Administration Intravenous Topical Tranexamic Acid Total Knee Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>patient diagnosis primary osteoarthritis patient diagnose primary OA patient anticoagulation therapy patient chronic renal failure patient CVA Hx Patient seizure Hx Patient severe CHF Patient acquire congenital coagulopathy</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Tranexamic acid</keyword>
</DOC>